Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2022 Filed Oct 5, 2022 20:02 UTC |
Amado RafaelEVP of R&D
|
Tax withholdingCommon Stock | 8,968 | $11.06 | $99,201.33 |
DisclosureSEC source: 0001593968-22-001495 · primary_01.xml · nonDerivative · entry 1 Amado Rafael · CIK 0001662119 · EVP of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,290 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.01 to $11.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes 1 share of the Issuer's common stock acquired by the reporting person on September 15, 2022 pursuant to an employee stock purchase program Read SEC document |
| August 12, 2022 Filed Aug 15, 2022 21:40 UTC |
WITTE OWEN N.Director
|
SaleCommon Stock | 5,000 | $17.25 | $86,250.00 |
DisclosureSEC source: 0001737287-22-000069 · primary_doc.xml · nonDerivative · entry 2 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,271 Read SEC document |
| August 12, 2022 Filed Aug 15, 2022 21:12 UTC |
WITTE OWEN N.Director
|
SaleCommon Stock | 5,000 | $17.25 | $86,250.00 |
DisclosureSEC source: 0001737287-22-000068 · primary_doc.xml · nonDerivative · entry 2 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,271 Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 21:40 UTC |
WITTE OWEN N.Director
|
SaleCommon Stock | 10,000 | $16.50 | $165,000.00 |
DisclosureSEC source: 0001737287-22-000069 · primary_doc.xml · nonDerivative · entry 1 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,271 Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 21:12 UTC |
WITTE OWEN N.Director
|
SaleCommon Stock | 10,000 | $16.50 | $165,000.00 |
DisclosureSEC source: 0001737287-22-000068 · primary_doc.xml · nonDerivative · entry 1 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,271 Read SEC document |
| August 02, 2022 Filed Aug 2, 2022 21:40 UTC |
Amado RafaelEVP of R&D and CMO
|
SaleCommon Stock | 2,000 | $11.97 | $23,940.00 |
DisclosureSEC source: 0001737287-22-000057 · primary_doc.xml · nonDerivative · entry 1 Amado Rafael · CIK 0001662119 · EVP of R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,257 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 20:48 UTC |
Mayo StephenDirector
|
GrantStock Option (Right to Buy) · Derivative | 54,487 | $0.00 Strike: $12.03 | $0.00 |
DisclosureSEC source: 0001737287-22-000053 · primary_doc.xml · derivative · entry 2 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,487 Underlying: Common Stock · 54,487 shares Expires 2032-07-08 F1 · derivative.exercise_date: 1. The shares subject to the stock option shall vest in a series of 36 successive equal installments measured from the date of grant. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 20:48 UTC |
Mayo StephenDirector
|
GrantCommon Stock | 35,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001737287-22-000053 · primary_doc.xml · nonDerivative · entry 1 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,328 Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 20:16 UTC |
Amado RafaelEVP of R&D and CMO
|
SaleCommon Stock | 2,000 | $11.44 | $22,880.00 |
DisclosureSEC source: 0001662119-22-000002 · primary_doc.xml · nonDerivative · entry 1 Amado Rafael · CIK 0001662119 · EVP of R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 542,257 F1 · kind: 1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 20:40 UTC |
WITTE OWEN N.Director
|
SaleCommon Stock | 10,000 | $11.76 | $117,600.00 |
DisclosureSEC source: 0001214659-22-008272 · marketforms-56519.xml · nonDerivative · entry 1 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,271 Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 20:47 UTC |
Amado RafaelEVP of R&D and CMO
|
SaleCommon Stock | 2,000 | $11.18 | $22,360.00 |
DisclosureSEC source: 0001214659-22-008241 · marketforms-56501.xml · nonDerivative · entry 1 Amado Rafael · CIK 0001662119 · EVP of R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,257 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:58 UTC |
Kazam Joshua ADirector
|
GrantCommon Stock | 44,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-008170 · marketforms-56492.xml · nonDerivative · entry 1 Kazam Joshua A · CIK 0001221355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,063 Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:58 UTC |
SATO VICKI LDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,535 | $9.62 Strike: $9.62 | $341,846.70 |
DisclosureSEC source: 0001214659-22-008171 · marketforms-56494.xml · derivative · entry 2 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,535 Underlying: Common Stock · 35,535 shares Expires 2032-06-15 F1 · derivative.exercise_date: Vesting in 12 equal monthly installments. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:58 UTC |
SATO VICKI LDirector
|
GrantCommon Stock | 22,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-008171 · marketforms-56494.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,451 Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:58 UTC |
Humer Franz BDirector
|
GrantCommon Stock | 44,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-008172 · marketforms-56491.xml · nonDerivative · entry 1 Humer Franz B · CIK 0001548072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,892 Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:58 UTC |
WITTE OWEN N.Director
|
GrantStock Option (Right to Buy) · Derivative | 35,535 | $0.00 Strike: $9.62 | $0.00 |
DisclosureSEC source: 0001214659-22-008169 · marketforms-56490.xml · derivative · entry 2 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,535 Underlying: Common Stock · 35,535 shares Expires 2032-06-15 F1 · derivative.exercise_date: Vesting in 12 equal monthly installments. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:58 UTC |
WITTE OWEN N.Director
|
GrantCommon Stock | 22,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-008169 · marketforms-56490.xml · nonDerivative · entry 1 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,271 Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:57 UTC |
Barrett Elizabeth A.Director
|
GrantStock Option (Right to Buy) · Derivative | 71,070 | $0.00 Strike: $9.62 | $0.00 |
DisclosureSEC source: 0001214659-22-008168 · marketforms-56493.xml · derivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,070 Underlying: Common Stock · 71,070 shares Expires 2032-06-15 F1 · derivative.exercise_date: Vesting in 12 equal monthly installments. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:57 UTC |
MESSEMER DEBORAH M.Director
|
GrantStock Option (Right to Buy) · Derivative | 71,070 | $0.00 Strike: $9.62 | $0.00 |
DisclosureSEC source: 0001214659-22-008166 · marketforms-56488.xml · derivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,070 Underlying: Common Stock · 71,070 shares Expires 2032-06-15 F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning July 15, 2022. Read SEC document |
| May 19, 2022 Filed May 19, 2022 21:40 UTC |
Amado RafaelEVP of R&D and CMO
|
SaleCommon Stock | 11,500 | $7.40 | $85,091.95 |
DisclosureSEC source: 0001214659-22-007226 · marketforms-56248.xml · nonDerivative · entry 1 Amado Rafael · CIK 0001662119 · EVP of R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546,257 F1 · kind: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.32 to 7.445, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes 280 shares of the Issuer's common stock acquired by the reporting person on September 15, 2021 pursuant to an employee stock purchase program. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 16:44 UTC |
PF Equity Holdings 2 B.V.10% owner
|
OtherCommon Stock | 22,032,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001883111-22-000001 · primary_doc.xml · nonDerivative · entry 1 PF Equity Holdings 2 B.V. · CIK 0001883111 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares transferred to its parent entity, Pfizer Inc., for no cash consideration. F1 · shares: Shares transferred to its parent entity, Pfizer Inc., for no cash consideration. F1 · price: Shares transferred to its parent entity, Pfizer Inc., for no cash consideration. Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 17:49 UTC |
Bhavnagri VeerGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 272,435 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0001214659-22-004370 · marketforms-55857.xml · derivative · entry 2 Bhavnagri Veer · CIK 0001808980 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,435 Underlying: Common Stock · 272,435 shares Expires 2032-03-23 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 17:49 UTC |
Bhavnagri VeerGeneral Counsel
|
GrantCommon Stock | 175,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-004370 · marketforms-55857.xml · nonDerivative · entry 1 Bhavnagri Veer · CIK 0001808980 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589,279 Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 21:52 UTC |
Amado RafaelEVP of R&D and CMO
|
GrantStock Option (Right to Buy) · Derivative | 368,589 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0001214659-22-004375 · marketforms-55855.xml · derivative · entry 2 Amado Rafael · CIK 0001662119 · EVP of R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,589 Underlying: Common Stock · 368,589 shares Expires 2032-03-23 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 21:52 UTC |
Amado RafaelEVP of R&D and CMO
|
GrantCommon Stock | 237,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-004375 · marketforms-55855.xml · nonDerivative · entry 1 Amado Rafael · CIK 0001662119 · EVP of R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,477 Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 21:50 UTC |
Belldegrun ArieDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,458,333 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0001214659-22-004372 · marketforms-55853.xml · derivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,458,333 Underlying: Common Stock · 1,458,333 shares Expires 2032-03-23 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 21:51 UTC |
Chang David DDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 2,195,512 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0001214659-22-004374 · marketforms-55851.xml · derivative · entry 1 Chang David D · CIK 0001611024 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,195,512 Underlying: Common Stock · 2,195,512 shares Expires 2032-03-23 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 21:51 UTC |
MOORE ALISONChief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 737,179 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0001214659-22-004373 · marketforms-55852.xml · derivative · entry 1 MOORE ALISON · CIK 0001754937 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737,179 Underlying: Common Stock · 737,179 shares Expires 2032-03-23 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 21:49 UTC |
SCHMIDT ERIC THOMASChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 368,589 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0001214659-22-004371 · marketforms-55856.xml · derivative · entry 3 SCHMIDT ERIC THOMAS · CIK 0001754403 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,589 Underlying: Common Stock · 368,589 shares Expires 2032-03-23 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 21:49 UTC |
SCHMIDT ERIC THOMASChief Financial Officer
|
GrantCommon Stock | 237,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-004371 · marketforms-55856.xml · nonDerivative · entry 1 SCHMIDT ERIC THOMAS · CIK 0001754403 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,904 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 17:59 UTC |
Bhavnagri VeerGeneral Counsel
|
SaleCommon Stock | 8,849 | $7.68 | $67,962.09 |
DisclosureSEC source: 0001214659-22-004086 · marketforms-55822.xml · nonDerivative · entry 1 Bhavnagri Veer · CIK 0001808980 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,841 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.64 to $7.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes 1021 shares of the Issuer's common stock acquired by the reporting person on March 15, 2022 pursuant to an employee stock purchase program. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:59 UTC |
Amado RafaelEVP of R&D and CMO
|
SaleCommon Stock | 5,169 | $7.71 | $39,847.82 |
DisclosureSEC source: 0001214659-22-004087 · marketforms-55824.xml · nonDerivative · entry 1 Amado Rafael · CIK 0001662119 · EVP of R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,119 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.69 to $7.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes 1360 shares of the Issuer's common stock acquired by the reporting person on March 15, 2022 pursuant to an employee stock purchase program. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:59 UTC |
Chang David DDirector · President and CEO
|
SaleCommon Stock | 23,648 | $7.65 | $180,878.82 |
DisclosureSEC source: 0001214659-22-004085 · marketforms-55821.xml · nonDerivative · entry 1 Chang David D · CIK 0001611024 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,289,652 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.59 to $7.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes 1021 shares of the Issuer's common stock acquired by the reporting person on March 15, 2022 pursuant to an employee stock purchase program. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:58 UTC |
SCHMIDT ERIC THOMASChief Financial Officer
|
SaleCommon Stock | 11,469 | $7.63 | $87,550.91 |
DisclosureSEC source: 0001214659-22-004084 · marketforms-55819.xml · nonDerivative · entry 1 SCHMIDT ERIC THOMAS · CIK 0001754403 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,546 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.59 to $7.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes 1021 shares of the Issuer's common stock acquired by the reporting person on March 15, 2022 pursuant to an employee stock purchase program. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:58 UTC |
MOORE ALISONChief Technical Officer
|
SaleCommon Stock | 8,698 | $7.63 | $66,388.35 |
DisclosureSEC source: 0001214659-22-004083 · marketforms-55823.xml · nonDerivative · entry 1 MOORE ALISON · CIK 0001754937 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,430 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.58 to $7.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes 1688 shares of the Issuer's common stock acquired by the reporting person on March 15, 2022 pursuant to an employee stock purchase program Read SEC document |
| March 14, 2022 Filed Mar 31, 2022 21:27 UTC |
Belldegrun ArieDirector
|
OtherCommon Stock | 4,710,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-004613 · marketforms-55916.xml · nonDerivative · entry 5 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,710,121 F3 · ownership.nature: These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,422.83. Read SEC document |
| March 14, 2022 Filed Mar 31, 2022 21:27 UTC |
Belldegrun ArieDirector
|
OtherCommon Stock | 4,710,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-004613 · marketforms-55916.xml · nonDerivative · entry 4 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F3 · ownership.nature: These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,422.83. Read SEC document |
| March 14, 2022 Filed Apr 1, 2022 21:40 UTC Amendment |
Belldegrun ArieDirector
|
OtherCommon Stock | 4,710,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-004729 · marketforms-55948.xml · nonDerivative · entry 3 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,710,120 F1 · balance_after: This amendment is being filed to correct the share holdings reported on the Form 4 filed by the reporting person on March 31, 2022. F2 · ownership.nature: These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,418.00. Read SEC document |
| March 14, 2022 Filed Apr 1, 2022 21:40 UTC Amendment |
Belldegrun ArieDirector
|
OtherCommon Stock | 4,710,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-004729 · marketforms-55948.xml · nonDerivative · entry 2 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · ownership.nature: These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,418.00. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 23:26 UTC |
Kazam Joshua ADirector
|
GiftCommon Stock | 412,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-003836 · marketforms-55743.xml · nonDerivative · entry 2 Kazam Joshua A · CIK 0001221355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,885 F1 · acquired: The transactions reported in this form did not involve a purchase or sale of securities by the reporting person. On March 7, 2022, the reporting person acquired securities previously held in trust for the benefit of the reporting person arising from the termination of the trust. On the same day, the reporting person transferred the same securities to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 23:26 UTC |
Kazam Joshua ADirector
|
OtherCommon Stock | 412,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-003836 · marketforms-55743.xml · nonDerivative · entry 1 Kazam Joshua A · CIK 0001221355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,503 F1 · acquired: The transactions reported in this form did not involve a purchase or sale of securities by the reporting person. On March 7, 2022, the reporting person acquired securities previously held in trust for the benefit of the reporting person arising from the termination of the trust. On the same day, the reporting person transferred the same securities to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 17:02 UTC |
Belldegrun ArieDirector
|
PurchaseCommon Stock | 155,039 | $12.60 | $1,953,491.40 |
DisclosureSEC source: 0001214659-22-000701 · marketforms-55052.xml · nonDerivative · entry 2 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 195,039 F1 · price: The reported securities were purchased by Bellco Legacy LLC at an average price of $12.60 per unit, calculated from the price range of $12.35 to $13.00. F2 · ownership.nature: The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 19:13 UTC |
Kazam Joshua ADirector
|
PurchaseCommon Stock | 15,000 | $12.60 | $189,000.00 |
DisclosureSEC source: 0001214659-22-000706 · marketforms-55053.xml · nonDerivative · entry 1 Kazam Joshua A · CIK 0001221355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,885 Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 21:55 UTC |
Amado RafaelEVP of R&D and CMO
|
SaleCommon Stock | 11,507 | $24.35 | $280,185.09 |
DisclosureSEC source: 0001214659-21-010210 · marketforms-53959.xml · nonDerivative · entry 1 Amado Rafael · CIK 0001662119 · EVP of R&D and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,928 F1 · kind: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.17 to $24.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:44 UTC |
Bhavnagri VeerGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001214659-21-009625 · marketforms-53823.xml · derivative · entry 3 Bhavnagri Veer · CIK 0001808980 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,300 Underlying: Common Stock · 5,000 shares Expires 2028-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:44 UTC |
Bhavnagri VeerGeneral Counsel
|
SaleCommon Stock | 5,000 | $24.77 | $123,844.50 |
DisclosureSEC source: 0001214659-21-009625 · marketforms-53823.xml · nonDerivative · entry 2 Bhavnagri Veer · CIK 0001808980 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,669 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.64 to $24.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:44 UTC |
Bhavnagri VeerGeneral Counsel
|
Exercise / conversionCommon Stock | 5,000 | $2.27 | $11,350.00 |
DisclosureSEC source: 0001214659-21-009625 · marketforms-53823.xml · nonDerivative · entry 1 Bhavnagri Veer · CIK 0001808980 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 316 shares of the Issuer's common stock acquired by the reporting person on September 15, 2021 pursuant to an employee stock purchase program. Read SEC document |
| September 09, 2021 Filed Sep 9, 2021 21:32 UTC |
WITTE OWEN N.Director
|
SaleCommon Stock | 5,000 | $25.54 | $127,700.00 |
DisclosureSEC source: 0001214659-21-009372 · marketforms-53760.xml · nonDerivative · entry 1 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,182 Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 20:22 UTC |
WITTE OWEN N.Director
|
SaleCommon Stock | 5,000 | $23.24 | $116,200.00 |
DisclosureSEC source: 0001214659-21-008900 · marketforms-53642.xml · nonDerivative · entry 2 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,182 Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 20:22 UTC |
WITTE OWEN N.Director
|
SaleCommon Stock | 5,000 | $23.70 | $118,500.00 |
DisclosureSEC source: 0001214659-21-008900 · marketforms-53642.xml · nonDerivative · entry 1 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,182 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.